Neuralink

Develops brain-computer interfaces for medical use

Fremont, California, United States

About Neuralink

Neuralink develops brain-computer interfaces (BCIs) that facilitate direct communication between the brain and external devices. Its main product, the N1 Implant, is a small, fully implantable device that allows users to control computers or mobile devices through their brain activity. The N1 Implant operates using a wirelessly charged battery and advanced low-power chips that process neural signals, which are then sent to the Neuralink Application to be translated into computer commands. A unique aspect of Neuralink is its use of a surgical robot that precisely inserts ultra-thin threads into the brain, minimizing damage during the procedure. This company stands out from competitors by focusing on both medical applications for individuals with mobility issues and the potential for cognitive enhancement for a broader audience. The goal of Neuralink is to restore autonomy to those with unmet medical needs and to explore new ways for humans to interact with technology.

Fremont, CaliforniaHeadquarters
2016Year Founded
$667.3MTotal Funding
SERIES_DCompany Stage
Robotics & Automation, AI & Machine Learning, HealthcareIndustries
201-500Employees

Benefits

An opportunity to change the world and work with some of the smartest and the most talented experts from different fields.
Growth potential. We rapidly advance team members who have an outsized impact.
Excellent medical, dental, and vision insurance through a PPO plan; parental leave.
Flexible time off + paid holidays.
Equity + 401(k) plan.
Commuter Benefits.
Meals provided.

Risks

Increased competition from startups like Inbrain challenges Neuralink's market position.
SEC investigation could harm Neuralink's reputation and investor confidence.
Regulatory challenges in new markets like Canada may delay product deployment.

Differentiation

Neuralink's N1 Implant offers a cosmetically invisible brain-machine interface solution.
The Blindsight device aims to restore vision for the blind, expanding product offerings.
Neuralink's surgical robot ensures precise implantation with minimal brain damage.

Upsides

Approval for Canadian trials opens international expansion opportunities for Neuralink.
The Texas facility construction shows commitment to scaling operations and production capacity.
Partnership with Toronto Western Hospital strengthens Neuralink's international research collaborations.

Funding

Total raised$667.29 M
Latest valuation$5.00 B
StageSERIES_D
SERIES D
7/31/2023
$323
$5.00 B
SECONDARY
6/30/2022
$10
SERIES B
3/31/2019
$51
$255.00 M
SERIES A
7/31/2017
$107
$535.00 M